Organization Overview
Historical Acquisition Tree
Alternative names
bortezomib (velcade) (2017)
busulfan (Myleran) (2017)
decitabine (dacogen) (2017)
ganciclovir (cytovene) (2017)
ipratropium (atrovent) (2001)
lamotrigine (lamictal) (2009)
Key: Pharmasciences (4) Acquired (4)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Lung Neoplasms (Phase 2)
Short Bowel Syndrome (Phase 2)
Syndrome (Phase 2)